A randomized study of midazolam versus dexmedetomidine for premedication in children via intranasal mucosal atomization device
Keywords:
dexmedetomidine, intranasal, midazolam, mucosal atomization device, paediatricAbstract
Many drugs have been tried for premedication in children[1] amongst which midazolam and dexmedetomidine are commonly used and are reportedly safe and effective for usage during both separation as well as induction of anaesthesia. Hence, we planned to carry out a study of midazolam versus dexmedetomidine for premedication in children via intranasal Mucosal Atomization Device. To compare the efficacy of midazolam and dexmedetomidine as premedication in children of 2 to 6 years of age via intranasal Mucosal Atomization Device. This randomized study was done at Dhiraj hospital, Piparia, Vadodara, Gujarat on 60 children belonging to American Society of Anaesthesiologists (ASA) physical status I or II of age 2-6 years of either gender undergoing elective surgeries under general anaesthesia. Children were separated into: Group M - Midazolam 0.2 mg/kg (preservative free) Group D - Dexmedetomidine 1µg/kg. Drug was administered 30 minutes prior to surgery and following parameters were assessed: Acceptance of drug, Sedation Score, behaviour during parental separation and mask acceptance. Dexmedetomidine was statistically significantly better in aspect of drug acceptance, sedation after 30 minutes of drug administration, parental separation and mask acceptance than midazolam.
Downloads
References
Malineni N, Patil MC. “Comparative evaluation of intranasal dexmedetomidine and intranasal midazolam for premedication in children undergoing anesthesia”: A 1-year double-blind randomized controlled trial. Indian J Health Sci Biomed Res 2017;10:155-9.
Kain ZN, Mayes LC, O’Connor TZ, Cicchetti DV. Preoperative anxiety in children: predictors and outcomes. Arch Pediatr Adolesc Med 1996; 150: 1238–45.
Kain ZN, Mayes LC, Caldwell-Andrews AA, Karas DE, McClain BC. Preoperative anxiety, postoperative pain, and behavioral recovery in young children undergoing surgery. Pediatrics. 2006 Aug; 118(2):651-8. doi: 10.1542/peds.2005-2920. PMID: 16882820.
Creedon LR, Dock M. Pharmacological management of patient behavior. In: McDonald RE, Avery DR, editors. Dentistry for the Children and Adolescent. 8th ed. St. Louis: CV Mosby; 2004. p. 285 311.
Tschirch FT,Gopfert K,Frohlich JM,Bruner G,Weishaupt D.Low-dose intranasal versus oral midazolam for routine body MRI of claustrophobic patients. Eur Radiol.2007;17:1403-10.[PubMed][Google Scholar].
Talon MD, Woodson LC, Sherwood ER, Aarsland A,McRae L, Benham T, et al.Intranasal dexmedetomidine premedication is comparable with midazolam in burn children undergoing reconstructive surgery.J Burn Care Res.2009;30:599- 605.[PubMed][Google Scholar].
Wang J,Bu G.Influence ofss intranasal medication on the structure of nasal mucosa.Chin Med J(Engl)2002;115:617-9.[PubMed][Google Scholar].
Yuen VM, Hui TW,Irwin MG,Yao TJ,Wong GL, Yuen MK, et al.Optimal timing for the administration of intranasal dexmedetomidine for premedication in children.Anaesthesia.2010;65:922-9.[PubMed][Google Scholar].
Wolfe TR, Braude DA. Intranasal medication delivery for children: a brief review and update. Paediatrics 2010;126:532-7. Crossers PubMed Web of Science R Google Scholar.
Parnis SJ, Foate JA, van der Walt JH, Short T, Crowe CE. Oral midazolam is an effective premedication for children having day-stay anaesthesia. Anaesth Intensive Care. 1992 Feb;20(1):9-14. doi: 10.1177/0310057X9202000102. PMID: 1609951.
Filos KS, Goudas LC, Patroni O, Polyzou V. Hemodynamic and analgesic profile after intrathecal clonidine in humans. A dose-response study. Anesthesiology.1994;81:591-601.[PubMed][Google Scholar].
Pandit UA, Collier PJ, Malviya S, VoepelLewis T, Wagner D, Siewert MJ. Oral transmucosal midazolam premedication for preschool children. Can J Anaesth 2001;48:191-5.
Mitchell V, Grange C, Black A, Train J. A comparison of midazolam with trimeprazine as an oral premedicant for children. Anaesthesia 1997;52:416
Medhat MM and Gamal Zakaria El-Morsy. Anaesth Essays Res. 2018 Jan- Mar; 12(1): 170-175. Doi:10.4103/aer.AER 119 17.PMID: 29628576.
Corrigan M, Wilson S, Hampton J. Safety and efficacy of intranasally administered medications in the emergency department and prehospital settings. Am J Health-Syst Pharm. 2015; 72: 1544-1554.
Björkman S, Rigemar G, Idvall J. Pharmacokinetics of midazolam given as an intranasal spray to adult surgical patients. Br J Anaesth. 1997;79:575–80. – PubMed.
Yildirim SV, Guc BU, Bozdogan N, Tokel K. Oral versus intranasal midazolam premedication for infants during echocardiographic study. Adv Ther. 2006;23:719–24. – PubMed.
Kumar A, Sinha C, Kumar A, Kumari P. The effect of intravenous dexmedetomidine compared to propofol on patients hemodynamics as a sedative in brachial plexus block: A comparative study. Anesth Essays Res 2017;11:201-5.
Xie Z, Shen W, Lin J, Xiao L, Liao M, Gan X. Sedation effects of intranasal dexmedetomidine delivered as sprays versus drops on pediatric response to venous cannulation. Am J Emerg Med. 2017 Aug;35(8):1126-1130. doi: 10.1016/j.ajem.2017.03.021. Epub 2017 Mar 18. PMID: 28347608.
Gupta A, Dalvi NP, Tendolkar BA. Comparison between intranasal dexmedetomidine and intranasal midazolam as premedication for brain magnetic resonance imaging in pediatric patients: A prospective randomized double blind trial. J Anaesthesiol Clin Pharmacol. 2017 Apr-Jun;33(2):236-240. doi: 10.4103/joacp.JOACP_204_16. PMID: 28781452; PMCID: PMC5520599.
Naik Shilpa S, Shrama Parul. To assess the Compliance and Sedation Score of Intranasal Midazolam and dexmedetomidine Premedication among Children. Indian J Anesth Analg. 2018;5(12):2062-66.
Diwan G, Bharti AK, Rastogi K, Gupta PK. Comparison of intranasal dexmedetomidine and midazolam as premedication in pediatric surgical patients: A prospective, randomized double-blind study. Anesth Essays Res 2020;14:384-9.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.